Carbutamide

Last updated
Carbutamide
Carbutamide.svg
Clinical data
Other namesGlybutamide
AHFS/Drugs.com International Drug Names
Routes of
administration 		Oral
ATC code
Identifiers
  • 4-amino-N-(butylcarbamoyl)benzenesulfonamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.005.841 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C11H17N3O3S
Molar mass 271.33 g·mol−1
3D model (JSmol)
  • O=S(=O)(c1ccc(N)cc1)NC(=O)NCCCC
  • InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15) X mark.svgN
  • Key:VDTNNGKXZGSZIP-UHFFFAOYSA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.

It is classified as first-generation. [1]

It was patented in 1953 and approved for medical use in 1956. [2]

See also

References

  1. ↑ Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Research and Clinical Practice. 8 (2): 109–114. doi:10.1016/0168-8227(90)90020-T. PMID   2106423.
  2. ↑ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 449. ISBN   9783527607495.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.